Althea is a public benefit company focused on enhancing the understanding of psychedelic programs' effects on health and consciousness. Their software tools are designed for service centers and facilitators to manage clients, measure outcomes, and ensure compliance with regulations, particularly in Oregon. Althea differentiates itself by providing pre-loaded compliance forms and automated outcome measurement tools, which are essential for reducing risks and improving safety in psychedelic therapy. The company aims to contribute to real-world evidence that can drive policy reform and improve access to psychedelic therapies, which are often expensive and not covered by insurance. Founded in 2023, Althea is positioned to play a significant role in the emerging psychedelic therapy market, especially with the upcoming Oregon Psilocybin Program.
Is this your company?
Something looks off?